Literature DB >> 12378995

Presentation and management of patients with initial negative 4-vessel cerebral angiography in subarachnoid hemorrhage.

N Khan1, B Schuknecht, Y Yonekawa.   

Abstract

The importance of repeat-angiography in patients with acute subarachnoid hemorrhage (SAH) and initial negative angiography has been reviewed in the light of our patient population (19 patients with initial negative angiography/168 patients with SAH). The type of SAH i.e., nontraumatic perimesencephalic SAH versus focal or generalized non perimesencephalic SAH, as well as the amount and distribution of blood on the initial CT examination are important factors in decision making. 3D-Angio-CT, in 3/5 patients, and MR-angiography (MRA) in 1/5 patients were complementary non-invasive methods to diagnose aneurysms on repeated examinations. Repeat-cerebral angiography confirmed the source of hemorrhage in 3 patients.

Entities:  

Mesh:

Year:  2002        PMID: 12378995     DOI: 10.1007/978-3-7091-6736-6_14

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  4 in total

1.  Yield of Repeat 3D Angiography in Patients with Aneurysmal-Type Subarachnoid Hemorrhage.

Authors:  R S Bechan; W J van Rooij; J P Peluso; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-22       Impact factor: 3.825

2.  High-concentration contrast media (HCCM) in CT angiography of the carotid system: impact on therapeutic decision making.

Authors:  Bernhard Schuknecht
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804

3.  The Potential Value of 320-Row Computed Tomography Angiography in Digital Subtraction Angiography-Negative Spontaneous Subarachnoid Hemorrhage Patients.

Authors:  Shengfeng Wu
Journal:  J Comput Assist Tomogr       Date:  2022 Mar-Apr 01       Impact factor: 1.826

4.  Repeat Catheter Angiography in Patients with Aneurysmal-Pattern Angiographically Negative Subarachnoid Hemorrhage.

Authors:  Cody L Nesvick; Soliman Oushy; Krishnan Ravindran; Lorenzo Rinaldo; Panagiotis Kerezoudis; Eelco F Wijdicks; Giuseppe Lanzino; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2021-06-28       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.